NYSE:ELANPharmaceuticals
A Look At Elanco (ELAN) Valuation As Strong Revenue Growth Meets Softer EPS Guidance
Earnings reaction and investor focus
Elanco Animal Health (ELAN) recently reported year on year revenue growth of 12.2% that came in ahead of expectations, while guidance for next quarter EPS fell short, creating a mixed starting point for investor debate.
See our latest analysis for Elanco Animal Health.
At a share price of $22.75, Elanco has seen a 1 day share price return of 1.61% but a 30 day share price return decline of 10.78%, while the 1 year total shareholder return of about 140%...